In the dynamic world of scientific research, every minute counts, and the margins for error are paper-thin. What if artificial intelligence could not only enhance experimentation but also free scientists from the burden of monotonous tasks? Enter Reshape, a visionary Danish startup built on the premise of “decoding nature.” By automating the visual elements of laboratory experiments, Reshape is breaking barriers in biotech and agricultural research. With a recent $20 million Series A funding round, the company is poised to scale its innovative technology across the U.S. and beyond.

The Vision Behind Reshape

Founded in Copenhagen in 2018, Reshape’s objective is to transform how researchers conduct visual assessments in laboratory settings. The company’s flagship product is a robotic imaging system equipped with advanced software and machine learning models that track critical visual changes, such as color and growth rates, from petri dishes and similar apparatuses. This automation enables continuous operation, allowing experiments to run 24/7 without direct human oversight, thereby enabling technicians to focus on more sophisticated tasks that require their expertise.

A Bridge Between Biology and Engineering

Reshape’s ambition resonates with the growing trend of treating biology as an engineering discipline. CEO Carl-Emil Grøn emphasizes the importance of making intangible biological processes measurable. “How does an object grow? How does it behave?” he explains. By answering these questions through sophisticated imaging techniques, Reshape aims to build a translation layer between natural phenomena and their molecular foundations.

The Birth of an Innovative Concept

The inception of Reshape was driven by Grøn’s personal experiences with the biotech industry. Engaging with his partner, who frequently juggled labor-intensive lab tasks, he discovered a shocking truth: much of the biotechnology field still relied on manual methods that could be automated. Determined to drive change, Grøn partnered with Daniel Storgaard and Magnus Madsen, launching a platform that captures high-resolution visual data while keeping meticulous records of conditions and changes.

Harnessing Machine Learning for Precise Observations

Reshape’s technology isn’t just about capturing images; it also incorporates robust AI models tailored to specific research needs. These machine learning algorithms can analyze various experiment types, from fungal growth observation to monitoring seed germination rates. For instance, agricultural companies can evaluate the efficacy of bio-pesticides with unprecedented speed and accuracy, completing four to ten times as many experiments compared to traditional methods.

• Customizable Models: Reshape offers clients the opportunity to train AI models specific to their unique experimental requirements, ensuring adaptability across diverse lab environments.
• Data Management: The platform supports cloud-based results and integrates smoothly with other biotech software systems, ranging from Benchling to simple Excel files.
• Enhanced Accuracy: By leveraging AI for visual assessments, Reshape clients can achieve an 80% reduction in false negatives, minimizing the risk of prematurely discounting experiments.

A Customer-Centric Business Model

With the aim of making its advanced technology accessible, Reshape operates on a subscription model, which incorporates hardware, machine learning capabilities, and continuous software updates. Importantly, the pricing is value-based, tailored to the specific needs and outcomes of each client, ensuring that investments yield substantial returns through accelerated research cycles.

Looking Ahead: Scaling Impact in the U.S. Market

Recently, Reshape secured an additional funding boost through a Series A round spearheaded by Astanor Ventures. This influx of capital will enable the startup to expand its operations significantly, focusing primarily on growing its footprint in the U.S. market, where two-thirds of its revenue is currently generated from European clients’ U.S. facilities. Notable clients include global leaders such as Syngenta and educational institutions like the University of Oxford.

Conclusion: Pioneering a New Era of Scientific Research

As Reshape gears up to scale its operations and refine its offerings, it stands at the forefront of a transformative shift in lab automation. The company not only simplifies complex processes but also redefines how data is captured and utilized in scientific explorations. By bridging the gap between the natural world and its engineered counterparts, Reshape embodies the essence of innovative thinking in biotechnology.

At fxis.ai, we believe that such advancements are crucial for the future of AI, as they enable more comprehensive and effective solutions. Our team is continually exploring new methodologies to push the envelope in artificial intelligence, ensuring that our clients benefit from the latest technological innovations.

For more insights, updates, or to collaborate on AI development projects, stay connected with fxis.ai.